What is the market doing?
What the tape says about ABBV
AbbVie is +37% over the past year while the S&P 500 is +23%: 15 points ahead of the market.
+37%
1-year return · S&P 500 +23%
- vs 200-day average
- +18%
vs 200-day average · a clear uptrend
- RSI (14)
- 74
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −1.2%
Below its 52-week high
Details›
- Last close2026-08-26
- $262.84
- 1 monthS&P 500 +3.7%
- +2.3%
- 1 yearS&P 500 +23%
- +37%
- 5 yearsS&P 500 +87%
- +170%
- vs 50-day average$242.03
- +8.6%
- 52-week high
- $266.10
- 52-week low
- $193.46
- Annualised volatility
- 27%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$1.2M
| Year | Return |
|---|---|
| 2026 (year to date) | +17% |
| 2025 | +33% |
| 2024 | +19% |
| 2023 | −0.23% |
| 2022 | +24% |
| 2021 | +32% |
| 2020 | +28% |
| 2019 | +1.5% |
| 2018 | −0.96% |
| 2017 | +60% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −0.25% |
| Feb | 10 | 9 of 10 | +5.1% |
| Mar | 10 | 7 of 10 | −1.1% |
| Apr | 10 | 4 of 10 | −1.2% |
| May | 10 | 6 of 10 | +0.27% |
| Jun | 10 | 5 of 10 | +1.9% |
| Jul | 11 | 7 of 11 | +2.9% |
| Aug | 11 | 6 of 11 | +1.9% |
| Sep | 10 | 5 of 10 | +2.3% |
| Oct | 10 | 5 of 10 | −0.79% |
| Nov | 10 | 9 of 10 | +7.6% |
| Dec | 10 | 7 of 10 | +2.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
Ranks #15 of 16 by Smart Score